Abbreviated Name

BRSCW Ref Set App: Morre (2009)

Lead Investigator

Morre, D. James — NOX Technologies

Coordinating Investigator

Zheng, Yingye — Fred Hutchinson Cancer Center

Involved Investigators

• Morre, D. James — NOX Technologies
• Zheng, Yingye — Fred Hutchinson Cancer Center

Abstract

No abstract availalbe.

Aims

To obtain preliminary indications of utility for serum detection of breast and ovarian cancer.

Analytic Method

sandwich ELISA

Comments

No comments available.

Outcome

Two markers were tested: NXOB826 + NXO34 ELISA on pooled case samples and individual control samples.

Secure Outcome

No secure outcome available.

Publications

• No publications available at this time for this protocol.

Biomarkers

• ENOX
• ENOX2
• NX034
• NXOB826

Data Collections

• No data collections available at this time for this protocol.

Start Date

Oct 29 2009

Estimated Finish Date

Aug 31 2010

Finish Date

Aug 31 2010

Protocol ID

324

Protocol Type

Reference Set

Fields of Research

• Proteomics

Collaborative Group

Breast and Gynecologic Cancers Research Group

Cancer Types

• Malignant neoplasm of breast